We are live on ! Find out more
ANAB icon

AnaptysBio

124 hedge funds and large institutions have $633M invested in AnaptysBio in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,356% more call options, than puts

Call options by funds: $5.03M | Put options by funds: $205K

3.25% more ownership

Funds ownership: 107.31%110.55% (+3.2%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 39

5% less funds holding

Funds holding: 131124 (-7)

14% less capital invested

Capital invested by funds: $733M → $633M (-$100M)

14% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 21

Holders
124
Holders Change
-7
Holders Change %
-5.34%
% of All Funds
2.09%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
39
Reduced
39
Closed
21
Calls
$5.03M
Puts
$205K
Net Calls
+$4.83M
Net Calls Change
+$4.47M
Name Holding Trade Value Shares
Change
Change in
Stake
EC
1
EcoR1 Capital
California
$153M
TCM
2
Tang Capital Management
California
$53.4M
Federated Hermes
3
Federated Hermes
Pennsylvania
$46.8M +$15.5M +700,910 +44%
BlackRock
4
BlackRock
New York
$36M -$1.1M -49,497 -3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$35.1M -$2.15M -96,844 -5%
BC
6
Boxer Capital
California
$26.4M
State Street
7
State Street
Massachusetts
$23.5M +$4.38M +197,786 +21%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$18.7M +$689K +31,090 +3%
WP
9
Woodline Partners
California
$18.7M +$1.92M +86,711 +10%
FLSM
10
Frazier Life Sciences Management
California
$18.3M
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$17.3M -$10.3M -465,800 -35%
DM
12
Deerfield Management
New York
$15.7M +$17.1M +772,000 New
Assenagon Asset Management
13
Assenagon Asset Management
Luxembourg
$14M +$15.2M +687,564 New
DTC
14
Deep Track Capital
Connecticut
$13.7M +$2.52M +113,787 +20%
SCM
15
Soleus Capital Management
Connecticut
$13.1M +$14.3M +643,575 New
RSCM
16
Rock Springs Capital Management
Maryland
$11.6M +$199K +9,000 +2%
GPP
17
Great Point Partners
Connecticut
$9.2M -$5.47M -246,882 -35%
PAI
18
Palo Alto Investors
California
$8.75M
BBA
19
Baker Bros. Advisors
New York
$8.67M
Geode Capital Management
20
Geode Capital Management
Massachusetts
$7.54M +$341K +15,386 +4%
Northern Trust
21
Northern Trust
Illinois
$6.86M +$1.5M +67,756 +25%
Blackstone Inc
22
Blackstone Inc
New York
$6.67M
LCM
23
Laurion Capital Management
New York
$5.34M +$1.23M +55,708 +27%
N
24
Nuveen
North Carolina
$5.11M -$3.56M -160,843 -39%
JP Morgan Chase
25
JP Morgan Chase
New York
$4.7M -$64.6K -2,917 -1%

ANAB Hedge Fund Activity: Q2 2022 in Review

124 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q2 2022, worth a combined $633M — down 14% from $733M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ANAB and 18 opened new positions — a net loss of 3 holders — while 39 trimmed existing stakes and 39 added.

The largest buyer was Deerfield Management, opening a new position worth an estimated $17.1M. The largest seller was Point72 Asset Management, cutting an estimated $10.3M.

  • 124 institutional investors held AnaptysBio (ANAB) as of Q2 2022, down from 131 in Q1 2022.
  • Funds reported $633M of AnaptysBio stock for Q2 2022, down 14% quarter-over-quarter.
  • 18 funds opened new AnaptysBio positions in Q2 2022 and 21 closed out, a net change of -3 holders.
  • The largest AnaptysBio buyer in Q2 2022 was Deerfield Management, an estimated $17.1M added.
  • The largest AnaptysBio seller in Q2 2022 was Point72 Asset Management, an estimated $10.3M sold.

Based on aggregated 13F filings for Q2 2022.